![]() |
市場調查報告書
商品編碼
1984175
NGS資料儲存市場:2026-2032年全球市場預測(按儲存類型、定序平台、資料類型、部署模式和最終用戶分類)NGS Data Storage Market by Storage Type, Sequencing Platform, Data Type, Deployment Mode, End User - Global Forecast 2026-2032 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計到 2025 年,NGS 資料儲存市場價值將達到 12.9 億美元,到 2026 年將成長到 14.2 億美元,到 2032 年將達到 25.7 億美元,複合年成長率為 10.31%。
| 主要市場統計數據 | |
|---|---|
| 基準年 2025 | 12.9億美元 |
| 預計年份:2026年 | 14.2億美元 |
| 預測年份 2032 | 25.7億美元 |
| 複合年成長率 (%) | 10.31% |
隨著定序活動在科研機構、臨床檢查室和製藥公司研發領域的快速發展,迫切需要重新思考基因組資料的儲存、保護和存取方式。不斷提高的定序通量和讀取長度,以及日益成長的檢測資料量和資料保留及可追溯性方面的監管要求,使得資料儲存從單純的營運消耗品轉變為影響實驗設計、合作模式和洞察時間的策略資產。忽視資料儲存的機構將面臨資料傳輸瓶頸、營運複雜性增加和分析速度減慢等問題。
定序資料儲存環境正經歷一場變革,其驅動力來自定序設備、資料管理軟體和部署模式的創新。提高吞吐量和讀取長度的設備發展趨勢,持續推動可擴展儲存和高頻寬傳輸能力的需求。同時,智慧分層、壓縮和元資料驅動編配等軟體技術的進步,正在減少原始資料收集和下游分析之間的摩擦。這些技術因素的共同作用,正在加速從單一的本地資料孤島轉變為融合邊緣、核心和雲端元素的更靈活的架構的轉變。
2025年關稅和貿易調整的實施,為依賴進口儲存組件和設備的企業在採購週期、硬體籌資策略和供應商選擇方面帶來了新的變數。關稅變化可能會增加某些硬體類別的相對成本,並改變供應商的經濟效益,迫使採購團隊重新評估總生命週期成本、供應商多元化以及資本支出和服務模式之間的平衡。為此,許多企業正在加速探索以軟體為中心的解決方案,將服務合約、託管儲存服務和儲存容量擴展與初始硬體採購解耦。
透過分析儲存類型、部署模式、最終用戶、排序平台和資料類型等方面的詳細情形,可以清楚地了解需求和功能的發展方向。就儲存類型而言,對於需要本地效能和控制的組織來說,硬體部署仍然至關重要;但對於缺乏內部系統工程能力的組織來說,包括諮詢、整合、支援和維護在內的服務正變得越來越重要。專門用於資料壓縮、資料管理和資料安全的軟體層起到放大器的作用,使現有基礎設施能夠在無需完全更換硬體的情況下實現更高的有效容量和更強大的管治。
區域趨勢在製定儲存策略方面發揮決定性作用,美洲、歐洲、中東和非洲以及亞太地區的監管、基礎設施和資金籌措環境各不相同。在美洲,成熟的雲端運算應用、生物技術領域強勁的私人投資以及先進的研究網路,催生了對可擴展、高效能儲存解決方案的強勁需求,這些解決方案需與分析和臨床資訊學緊密整合。北美機構通常優先考慮支援互通性、高速資料輸出以支援協作計劃以及快速容量擴展的服務合約。
序列資料儲存領域的競爭格局涵蓋了成熟的基礎設施供應商、專業的儲存軟體供應商以及提供託管儲存和整合服務的服務公司。硬體供應商在效能、能源效率和模組化方面競爭,而軟體供應商則透過先進的壓縮演算法、元資料為中心的資料管理以及諸如靜態和傳輸中加密、基於角色的存取控制和審計日誌等安全功能來脫穎而出。服務供應商透過提供諮詢和系統整合服務,彌合原始容量與實際運作準備之間的差距,從而發揮日益重要的策略作用。
產業領導者應採取務實且多管齊下的方法,使儲存架構與科學研究目標、合規要求和財務限制相契合。首先,應建立清晰的管治和資料生命週期策略,以明確資料保留期限、存取控制和資料來源等方面的要求。這可以確保儲存決策以已記錄的營運需求為指導,而非隨意選擇。同時,應重新思考架構,將順序工作流程對應到儲存層級。優先考慮低延遲、高吞吐量的資源,用於即時採集原始資料和進行初步分析;為中間資料分配託管雲端儲存或物件儲存;並在符合監管和可重複性要求的情況下,部署經濟高效的冷儲存層或磁帶,用於長期歸檔。
本研究整合了定性和定量資訊,以全面了解序列資料儲存。調查方法結合了對資深儲存架構師、生物資訊學經理和採購負責人的專家訪談,以了解實際操作情況和實施障礙。對長讀長和短讀長平台儲存模式和文件類型的技術評估,有助於分析效能需求和分層策略。來自學術、臨床和商業實驗室的案例研究,為架構選擇和操作權衡提供了實際檢驗。
高通量定序、不斷變化的監管預期以及供應鏈經濟格局的轉變,使得儲存從單純的後台功能躍升為對科研和臨床成果具有重大影響的戰略領域。那些基於管治、分層架構和軟體最佳化,並採取審慎的、分階段的儲存策略的機構,更有能力維持科研效率、保護敏感數據,並應對政策和成本壓力。資訊科技、生物資訊學、採購和法務部門之間的策略協作至關重要,以確保儲存選擇能夠提升長期營運韌性,而非僅僅追求短期便利。
The NGS Data Storage Market was valued at USD 1.29 billion in 2025 and is projected to grow to USD 1.42 billion in 2026, with a CAGR of 10.31%, reaching USD 2.57 billion by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 1.29 billion |
| Estimated Year [2026] | USD 1.42 billion |
| Forecast Year [2032] | USD 2.57 billion |
| CAGR (%) | 10.31% |
The rapid expansion of sequencing activities across research institutions, clinical laboratories, and pharmaceutical R&D has created an urgent need to rethink how genomic data is stored, protected, and accessed. Advances in throughput and read length, combined with increasingly data-rich assays and regulatory demands for retention and traceability, have elevated storage from an operational commodity to a strategic asset that influences experimental design, collaboration models, and time-to-insight. Organizations that treat storage as an afterthought face bottlenecks in data transfer, rising operational complexity, and compromised analytical velocity.
Today's storage environment must reconcile competing imperatives: high-performance access for active analysis, cost-effective archiving for long-term regulatory and scientific reproducibility, robust security to safeguard sensitive patient and proprietary data, and flexible deployment to support distributed collaborations. The evolution of cloud-native architectures, tiered storage approaches, and specialized compression and data management tools is reshaping how institutions architect end-to-end sequencing pipelines. Consequently, storage strategy now plays a central role in enabling scalable, compliant, and economically sustainable genomic workflows.
This introduction frames the report's purpose: to examine technological dynamics, policy shifts, and operational practices that determine how sequencing-generated data is preserved and mobilized. By synthesizing technological developments, procurement considerations, and user needs, the following sections present actionable insights for leaders planning storage investments that align with scientific and commercial objectives.
The landscape for sequencing data storage is undergoing transformative shifts driven by innovations in sequencing instrumentation, data management software, and deployment paradigms. Instrumentation trends that increase throughput and read lengths create a persistent demand for scalable storage and high-bandwidth transfer capabilities, while software advancements such as intelligent tiering, compression, and metadata-driven orchestration reduce friction between raw data acquisition and downstream analytics. Together, these technological vectors are accelerating the shift from monolithic on-premises silos toward more fluid architectures that blend edge, core, and cloud elements.
Concurrently, the maturation of cloud ecosystems has altered procurement and operational models. Organizations are increasingly adopting hybrid approaches that keep latency-sensitive workloads close to compute resources while leveraging cloud capacity for burst analysis and long-term archiving. This hybrid posture allows institutions to optimize total cost of ownership without sacrificing analytical performance. At the same time, rising attention to data sovereignty, privacy, and cross-border collaboration is prompting more nuanced deployment choices and supplier due diligence processes.
Operational practices are also evolving. Data governance frameworks, reproducible pipelines, and standardized data formats have emerged as prerequisites for collaborative science and clinical translation. As a result, storage strategies that integrate policy controls, provenance tracking, and automation enjoy stronger adoption. These transformative shifts collectively demand that stakeholders adopt a forward-looking view of storage as an adaptable platform that underpins research agility and clinical reliability.
The introduction of tariffs and trade adjustments in 2025 has introduced new variables into procurement cycles, hardware sourcing strategies, and vendor selection for organizations reliant on imported storage components and appliances. Tariff changes increase the relative cost of certain hardware categories and may shift vendor economics, prompting procurement teams to revisit total lifecycle costs, supplier diversification, and the balance between capital expenditure and service-based models. In response, many organizations are accelerating explorations of service agreements, managed storage offerings, and software-centric solutions that decouple storage capacity growth from upfront hardware purchases.
Tariffs also influence supplier negotiations and regional sourcing strategies. Organizations that previously relied on single-source procurement for specific appliance models are reconsidering multi-vendor approaches and local distribution partners to mitigate supply-chain volatility. This has spurred renewed interest in modular architectures that allow incremental expansion using components from alternative suppliers, reducing dependency on tariff-affected SKUs. For software and cloud-native solutions, the impact is subtler but still material: increased hardware costs can shift buyer preferences toward subscription models, cloud capacity, and tiered retention strategies that emphasize compression and lifecycle policies.
Regulatory compliance and interoperability concerns further shape responses to tariff-driven cost pressures. Institutions must ensure that cost-optimization measures do not compromise data integrity, provenance, or access controls. As a result, finance, procurement, and scientific leadership are collaborating more closely to align sourcing with operational priorities, ensuring that storage decisions reflect both fiscal prudence and research continuity.
Analyzing segmentation across storage types, deployment modes, end users, sequencing platforms, and data types reveals distinct vectors of demand and capability. When storage type is considered, hardware adoption remains foundational for organizations requiring on-premises performance and control, while services encompassing consulting, integration, and support and maintenance are increasingly critical for institutions that lack in-house systems engineering capacity. Software layers focused on data compression, data management, and data security act as force multipliers, enabling existing infrastructure to deliver higher effective capacity and stronger governance without wholesale hardware replacement.
Deployment mode differentiation highlights how cloud, hybrid, and on-premises strategies map to institutional priorities. Pure cloud approaches provide elasticity and simplified vendor management for teams comfortable with remote governance, whereas hybrid models combine on-premises performance for active workloads with cloud scalability for archival and burst compute. Private cloud variants offer more control for regulated environments, while public cloud platforms enable rapid scaling and integration with managed analytics services.
End-user segmentation underscores varied requirements: academic and research institutes, including government research labs and universities, prioritize flexibility, collaboration, and open standards; healthcare providers such as hospitals and clinics demand stringent privacy controls, auditability, and integration with clinical systems; pharmaceutical and biotechnology companies, spanning biotech SMEs and large pharma, focus on high-throughput integrity, chain-of-custody for IP, and optimized workflows that accelerate drug discovery. Sequencing platform choice also drives storage characteristics: long read systems such as those from Oxford Nanopore and PacBio generate distinct file profiles and access patterns compared with short read technologies from Illumina and MGI, influencing compression strategies, index structures, and compute co-location. Finally, data type segmentation differentiates archived cold storage and tape for long-term retention from processed formats like BAM and VCF used for secondary analysis, and raw formats such as BCL and FASTQ that require rapid ingest pipelines and temporary high-performance storage. Understanding how these segments intersect enables tailored architectures that meet performance, compliance, and cost objectives across diverse use cases.
Regional dynamics play a decisive role in shaping storage strategies, with distinctive regulatory, infrastructure, and funding environments across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, mature cloud adoption, robust private investment in biotech, and advanced research networks create strong demand for scalable, high-performance storage solutions that integrate tightly with analytics and clinical informatics. North American institutions frequently prioritize interoperability, fast data egress for collaborative projects, and service agreements that support rapid capacity expansion.
The Europe, Middle East & Africa region faces a complex mosaic of data sovereignty requirements and heterogeneous infrastructure maturity. Organizations here place a premium on deployment models that support localized control, rigorous privacy safeguards, and vendor solutions that align with multijurisdictional compliance regimes. This drives preference for hybrid architectures and private cloud implementations that can be configured to local regulatory frameworks. Additionally, collaborative consortia and pan-regional research initiatives often necessitate standardized data management practices and provenance tracking.
Asia-Pacific presents a dynamic mix of high-growth markets, substantial sequencing capacity expansion, and varying regulatory frameworks. Rapidly expanding research and clinical genomics programs are increasing demand for both on-premises appliances in regions with constrained connectivity and cloud-native models in areas with robust network infrastructure. Across these regions, regional supply chains, tariff exposure, and local vendor ecosystems shape procurement decisions, making geographically informed sourcing and deployment strategies essential for resilient operations.
The competitive landscape for sequencing data storage encompasses established infrastructure vendors, specialized storage software providers, and service firms that offer managed storage and integration services. Hardware vendors compete on performance, energy efficiency, and modularity, while software suppliers differentiate through advanced compression algorithms, metadata-centric data management, and security features such as encryption at rest and in transit, role-based access controls, and audit logging. Service providers play an increasingly strategic role by delivering consulting and systems integration that bridge the gap between raw capacity and operational readiness.
Partnerships and ecosystem plays are a recurring theme: system integrators and cloud providers are collaborating with sequencing platform manufacturers and bioinformatics software makers to offer validated stacks that reduce time to deployment and operational risk. Vendor openness to interoperability and standards-based APIs accelerates integration with pipeline orchestration tools and laboratory information management systems, which in turn reduces bespoke engineering effort for end users. For procurement teams, vendor evaluation must balance technical fit with support capabilities, certification pathways for clinical use, and demonstrated experience in regulated environments.
Finally, innovation in the vendor community continues to lower barriers to adoption for organizations with limited IT resources by offering managed capacity, data lifecycle automation, and consumption-based pricing models that align cost with usage patterns, allowing science teams to focus on results rather than infrastructure management.
Industry leaders should adopt a pragmatic, multi-pronged approach that aligns storage architecture with scientific objectives, compliance needs, and financial constraints. Begin by establishing clear governance and data lifecycle policies that define retention periods, access controls, and provenance requirements so that storage decisions follow documented operational imperatives rather than ad hoc choices. Simultaneously, conduct an architecture review that maps sequencing workflows to storage tiers: prioritize low-latency, high-throughput resources for active raw-data ingest and primary analysis; designate managed cloud or object storage for intermediate processed data; and implement cost-efficient cold tiers or tape for long-term archival where regulatory and reproducibility needs permit.
Procurement strategies should include supplier diversification, contract terms that protect against tariff-driven volatility, and evaluation of service-based alternatives that transform capital expenses into operational expenditures. Invest in data management software that provides compression, indexing, and metadata-driven automation to maximize usable capacity and streamline retrieval. Strengthen cross-functional collaboration between IT, bioinformatics, legal, and laboratory operations to ensure that storage solutions meet security, performance, and compliance objectives.
Finally, pilot hybrid models that co-locate compute and storage where low latency is critical while leveraging cloud elasticity for peak demand and disaster recovery. Use pilot outcomes to build business cases for broader rollouts, and ensure continuous monitoring of performance, costs, and regulatory posture to adapt strategy as technologies and policies evolve.
This research synthesized qualitative and quantitative inputs to produce a comprehensive perspective on sequencing data storage. The methodology combined expert interviews with senior storage architects, bioinformatics leads, and procurement officers to capture operational realities and adoption barriers. Technical assessments of storage patterns and file profiles across long read and short read platforms informed analysis of performance requirements and tiering strategies. Case studies from academic, clinical, and commercial labs provided real-world validation of architecture choices and operational trade-offs.
Data collection included vendor product literature review and hands-on evaluation of representative storage software, compression tools, and integration capabilities. The research prioritized reproducible evidence such as benchmarked ingest rates, compression efficacy on relevant file types, and documented compliance features. Analytical frameworks focused on aligning storage capabilities with use-case requirements, assessing total lifecycle risks associated with procurement and tariff exposure, and mapping regional regulatory influences to deployment choices.
Throughout, findings were triangulated across multiple sources to reduce bias and ensure that recommendations reflect operational feasibility. Where proprietary data or client-specific concerns arose, anonymized examples were used to illustrate decision pathways without compromising confidentiality. The resulting methodology balances technical rigor with practical applicability for stakeholders planning storage modernization initiatives.
The confluence of high-throughput sequencing, evolving regulatory expectations, and shifting supply-chain economics has elevated storage from a background utility to a strategic domain that materially affects scientific and clinical outcomes. Organizations that adopt intentional, segment-aware storage strategies-grounded in governance, tiered architectures, and software-enabled optimization-will be better positioned to sustain research productivity, protect sensitive data, and respond to policy and cost pressures. Strategic alignment across IT, bioinformatics, procurement, and legal functions is essential to ensure storage choices serve long-term operational resilience rather than short-term convenience.
Across regions and end-user types, the optimal balance between on-premises, hybrid, and cloud approaches depends on performance needs, regulatory constraints, and connectivity realities. Likewise, tariff and supply-chain dynamics underscore the value of flexible procurement and an emphasis on software and service models that minimize exposure to capital cost fluctuations. Ultimately, the organizations that treat storage as a managed, evolving capability-incorporating automation, provenance tracking, and vendor interoperability-will unlock faster insights, reduce risk, and achieve more sustainable operations as sequencing workloads continue to scale.
This concluding perspective underscores the central premise of the report: storage decisions are strategic choices that directly influence the pace of discovery and the viability of clinical translation, and they deserve the same level of governance and investment as the sequencing platforms and analytics pipelines they support.